Enver Özkurt

Istanbul Florence Nightingale Hospital — Turkey

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index398citations72works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(45), Breast Lesions and Carcinomas(29), Breast Implant and Reconstruction(12), Cancer and Skin Lesions(11), Cancer Treatment and Pharmacology(8)

Publications72 total

Abstract PS4-08-08: Comparison of localization techniques for non-palpable breast cancer: real world data
Clinical Cancer Research·2026
Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study
Asian Pacific Journal of Cancer Prevention·2025Open Access
Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long‐Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut‐Offs
World Journal of Surgery·2025· 1 citedOpen Access
Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye
European Journal of Public Health·2025Open Access
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons
Langenbeck s Archives of Surgery·2025· 1 citedOpen Access
Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study
Clinical Cancer Research·2025
Abstract P3-07-14: Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study
Clinical Cancer Research·2025
Abstract P4-06-06: The Etiologic Causes of Diagnostic Delay in Locally Advanced Breast Cancer: _x000B_A Multicentric Nationwide Trial
Clinical Cancer Research·2025
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
World Journal of Surgery·2025· 3 citedOpen Access
ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03
Annals of Surgical Oncology·2025
Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study
Clinical Breast Cancer·2025· 3 cited
Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study
European Journal of Surgical Oncology·2025· 3 cited
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer
JAMA Surgery·2025· 14 citedOpen Access
Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
European Journal of Breast Health·2025· 1 citedOpen Access
Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy
Journal of Breast Cancer·2025Open Access
Evaluating the efficacy of preoperative radiotherapy in breast cancer patients non-responsive to neoadjuvant chemotherapy: A clinical trial
Biomedical Research and Therapy·2024Open Access
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03
Annals of Surgical Oncology·2024· 7 cited
Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided
Cancer·2024· 6 citedOpen Access
Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study
Cancer Research·2024· 2 cited
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
European Journal of Breast Health·2024Open Access
page 1 of 4Next →

Frequent Co-authors

Vahit Özmen(27), Abdullah İğci(26), Neslihan Cabıoğlu(25), Mustafa Tükenmez(24), Mahmut Müslümanoğlu(20), Selman Emiroğlu(18), Hasan Karanlık(13), Ravza Yılmaz(12), Semen Önder(9), Güldeniz Karadeniz Çakmak(7), Yeliz Emine Ersoy(6), Kamuran İbiş(6), Adnan Aydıner(6), Süleyman Bademler(6), Çetın Ordu(6), Cihan Uras(5), Baha Zengel(5), Ayfer Kamalı Polat(5), Halil Kara(5), Didem Can Trabulus(5)